2023
Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening
Cartmel B, Fucito L, Bold K, Neveu S, Li F, Rojewski A, Gueorguieva R, O'Malley S, Herbst R, Toll B. Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening. Journal Of Thoracic Oncology 2023, 19: 643-649. PMID: 37977486, PMCID: PMC10999350, DOI: 10.1016/j.jtho.2023.11.012.Peer-Reviewed Original ResearchStandard of careLung cancer screeningCancer screeningQuit ratesGain-framed messagingPack-year smoking historySmoking cessation ratesSmoking quit ratesNumber of cigarettesTobacco treatment interventionsYears of ageCessation/reductionChi-square testSelf-reported numberSmoking historyStandard careCessation ratesRandomized trialsTobacco treatmentTobacco cessationBiomarker feedbackLung cancerSmoking abstinencePost randomizationSmoking behavior
2022
Examining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening
Bold KW, Cannon S, Ford BB, Neveu S, Sather P, Toll BA, Fucito LM. Examining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening. Cancer Prevention Research 2022, 15: 327-333. PMID: 35063942, PMCID: PMC9064926, DOI: 10.1158/1940-6207.capr-21-0398.Peer-Reviewed Original ResearchConceptsLung cancer screeningCancer screeningTobacco treatmentWithdrawal symptomsRace/ethnicityTreatment perceptionsUS Preventive Services Task ForceHealth disparitiesAnnual lung cancerSmilow Cancer HospitalYale-New HavenCharacteristics of patientsHigh-risk patientsHigh-risk populationNon-Hispanic blacksTobacco-related health disparitiesAddress health disparitiesPatient characteristicsSmoking historyBlack patientsCancer HospitalLung cancerHigh riskPatientsSmoking
2021
Use and perceptions of electronic nicotine delivery systems among patients attending lung cancer screening who smoke
Fucito LM, Bold KW, Baldassarri SR, LaVigne JP, Ford B, Sather P, O'Malley SS, Toll BA. Use and perceptions of electronic nicotine delivery systems among patients attending lung cancer screening who smoke. Preventive Medicine Reports 2021, 23: 101444. PMID: 34235048, PMCID: PMC8250441, DOI: 10.1016/j.pmedr.2021.101444.Peer-Reviewed Original ResearchElectronic nicotine delivery systemsLung cancer screeningLow-dose CT scansNicotine delivery systemsSmoking cessationCancer screeningLung cancerOlder individualsTobacco harm reduction strategiesDecision-making visitHeavy smoking historyUse of ENDSSmoking-related illnessesCombustible tobacco productsPublic health campaignsHarm reduction strategiesQuarter of participantsClinical characteristicsCurrent smokingSmoking historyCT scanCommon reasonENDS useHealth campaignsDelivery system
2018
Chapter 12 Tobacco Use Disorder and Treatment
Fucito L, Baldassarri S. Chapter 12 Tobacco Use Disorder and Treatment. 2018, 183-196. DOI: 10.1016/b978-0-323-48565-4.00012-6.Peer-Reviewed Original ResearchTobacco use disorderLung cancer outcomesUse disordersOncology providersTobacco cessationCancer outcomesLung cancerTobacco useLong-term quit ratesBrief cessation adviceTobacco cessation interventionsTobacco cessation treatmentClinical practice guidelinesLung cancer patientsMajor risk factorLung cancer riskImportant teachable momentTobacco use statusCessation advicePharmacologic treatmentCessation treatmentWorse prognosisCessation interventionsCessation supportEfficient intervention strategies
2017
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer
Bold KW, Toll BA, Cartmel B, Ford BB, Rojewski AM, Gueorguieva R, O'Malley SS, Fucito LM. Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer. The Journal Of Smoking Cessation 2017, 13: 244-247. PMID: 32431757, PMCID: PMC7236885, DOI: 10.1017/jsc.2017.24.Peer-Reviewed Original ResearchLung cancerTobacco treatmentBiomarker feedbackCessation/reductionStandard careExpired carbon monoxideLung cancer screeningPoint prevalence abstinenceCurrent smokersLung functionPrimary outcomeCessation ratesCessation therapyCancer screeningQuit ratesSkin carotenoidsPlasma bilirubinGain-framed messagesNovel biomarkersPatientsNovel interventionsCancerPast weekSequential interventionsGain-framed messaging
2016
Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA, Committee F. Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016, 122: 1150-1159. PMID: 26916412, PMCID: PMC4828323, DOI: 10.1002/cncr.29926.Peer-Reviewed Original ResearchConceptsLung cancer screeningSmoking cessation interventionUS Preventive Services Task ForceLow-dose computed tomographyCancer screeningSmoking cessationTobacco useEvidence-based smoking cessation interventionsAge 55Evidence-based smoking cessation treatmentLung cancer screening participantsAnnual lung cancerPatients age 55Pack-year historySmoking cessation effortsSmoking cessation servicesSmoking cessation treatmentHigh-risk groupEvidence-based treatmentsEvidence-based behavioral strategiesScreening participantsLung cancerClinical guidelinesClinical recommendationsPremature mortality